Catalent

Heading to Arizona for Meeting on the Mesa? We'll see you there! Our experts will be joining discussions across the event, with John Tomtishen exploring effective CMC strategies across cell therapy modalities, and Philip Wills sharing insights on next-generation Rep/Cap technology for AAV production and innovative commercial models for rare diseases. Book some time with our team in Phoenix: https://ow.ly/o3gi50ZTHhR #MeetingOnTheMesa #CellTherapy #GeneTherapy #AAV #RareDisease #Catalent

October is Disability Employment Awareness Month, a time to recognize the value and talent of employees with disabilities and the important contributions they make across our organization. At Catalent, our ADAPT Employee Resource Group helps advance disability inclusion by fostering understanding, accessibility and a culture where every colleague has the opportunity to contribute. “Disability inclusion begins with a workplace where every employee feels valued and encouraged to do their best work,” said Trish Hunt, Group Vice President and Chief Marketing Officer, Catalent, and Executive Sponsor of ADAPT. “When we create that kind of environment and provide access to opportunities, people engage with confidence and help ensure our Patient First value is reflected in the work we do each day,” she added. This month, ADAPT will lead conversations on accessibility, inclusion and how emerging technologies, including AI, can help reduce barriers in the workplace. We are proud to celebrate the value and talent of employees with disabilities and reaffirm our commitment to building a workplace where everyone can thrive. #Inclusion #DEAM2026

Micronization can improve the performance of poorly soluble drug compounds, but reducing particle size is only part of the equation. Catalent’s latest expert content explores why understanding an API’s solid-state properties is critical when developing a successful particle engineering strategy. Discover how a multi-technique analytical approach can help identify risks earlier, inform process decisions, support successful scale-up, and maintain consistent product quality from early development through commercial manufacturing. Download the article: https://ow.ly/7JAl50ZTAiX #Micronization #ParticleEngineering #SolidStateCharacterization #DrugDevelopment #Bioavailability #AnalyticalScience #PharmaceuticalDevelopment #CDMO

A big thank you to everyone who joined us yesterday at the 2026 BioNJ Manufacturing Summit hosted at our Princeton Cell Therapy Center of Excellence. The event brought together leaders from across New Jersey's life sciences community to discuss the trends, challenges, and opportunities shaping the future of biopharmaceutical manufacturing, from supply chain resilience and advanced therapies to innovation, investment, and patient access. We were proud to showcase our Princeton facility and facilitate meaningful conversations on how collaboration across the industry can help accelerate innovation and improve outcomes for patients. Thank you to BioNJ, our speakers, panelists, and attendees for making this event such a success. #BioNJ #Biomanufacturing #CellTherapy #GeneTherapy #AdvancedTherapies #LifeSciences #Catalent

Thank you to everyone who joined us at our recent Smarter Development  to De-Risk,  Accelerate & Advance Your Molecule Together in Copenhagen. The event brought together biotech innovators, investors, and development experts for insightful discussions on early-stage drug development, formulation strategies, fundability, and innovation in oral drug delivery. From exploring PBPK modelling and Quality by Design approaches to engaging panel discussions on the scientific and strategic drivers of early-stage funding, the day was filled with valuable knowledge sharing and networking opportunities. A particular highlight was our VC Panel Discussion: Scientific and Strategic Drivers of Early-Stage Fundability, where venture capital and industry leaders across the globe shared their perspectives on what drives investment decisions, common challenges faced by emerging biotech companies, and how early development strategies can strengthen investor confidence. The discussion provided attendees with practical insights into aligning scientific excellence with commercial and funding objectives. A special thank you to our speakers, panelists, and attendees for contributing to such engaging conversations and making the event a success. We look forward to continuing these discussions and supporting the advancement of innovative therapies. #Catalent #EarlyDevelopment #DrugDevelopment #Biotech #PharmaInnovation #OralDrugDelivery #Fundability #PharmaceuticalDevelopment #LifeSciences #NordicBiotech #Copenhagen

That’s a wrap on BioProduction Congress in Lyon! It was a fantastic few days connecting with the biopharma community, exchanging ideas and discussing the latest developments shaping biologics development and manufacturing. A big thank you to everyone who stopped by to meet the Catalent team and share their perspectives, we really appreciate it! #BioProductionCongress #Biologics #Biomanufacturing #Biopharma #DrugDevelopment

During Hispanic Heritage Month, we’re celebrating the experiences and perspectives that help shape our culture at Catalent. In this employee spotlight, Gabriela Estupiñán and Jeferson Mendoza, members of Catalent’s LEAD (Latinos for Engagement, Advancement & Development) employee resource group steering committee, share how their heritage has influenced the way they build relationships, foster belonging and commit to Championing the Missions that Matter. Read more about their reflections in this article. #HispanicHeritageMonth #Belonging #Inclusion 

As clinical trials become more complex and patient-centric, is your supply strategy keeping pace? Catalent’s latest executive summary explores how flexible, demand-led approaches can help sponsors reduce waste, respond faster to changing trial needs and get therapies to patients more efficiently. Discover how models including FastChain® demand-led supply can support adaptive trials, accelerate country launches and virtually eliminate IMP waste, plus how Direct-to-Patient delivery helped reduce transport times by 78% in one case study. Download the executive summary: https://ow.ly/2B3550ZS8KM #ClinicalTrials #ClinicalSupply #ClinicalDevelopment #SupplyChain #PatientCentricity #Biopharma #Catalent

Last week, we celebrated a very special milestone in San Diego: 21 years of Catalent Blues Fest! This year's event brought together customers, partners, employees, friends, and families for an unforgettable evening of live music, great food, family fun, and celebration. Thank you to everyone who joined us and helped make Blues Fest 2026 one to remember. We loved celebrating with you and look forward to seeing you again next year! #Catalent #CatalentBluesFest #LifeAtCatalent #EarlyDevelopment #ClinicalSupply #SanDiegoLifeSciencesCommunity